Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
- Autores
- Rivera, Lidys; Siddaiah, Roopa; Oji Mmuo, Christiana; Silveyra, Gabriela Romina; Silveyra, Patricia
- Año de publicación
- 2016
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Bronchopulmonary dysplasia (BPD) is a chronic inflammatory lung disease of very-low-birth-weight (VLBW) preterm infants, associated with arrested lung development and a need for supplemental oxygen. Over the past few decades, the incidence of BPD has significantly raised as a result of improved survival of VLBW infants requiring mechanical ventilation. While early disease detection is critical to prevent chronic lung remodeling and complications later in life, BPD is often difficult to diagnose and prevent due to the lack of good biomarkers for identification of infants at risk, and overlapping symptoms with other diseases, such as pulmonary hypertension (PH). Due to the current lack of effective treatment available for BPD and PH, research is currently focused on primary prevention strategies, and identification of biomarkers for early diagnosis, that could also represent potential therapeutic targets. In addition, novel histopathological, biochemical, and molecular factors have been identified in the lung tissue and in biological fluids of BPD and PH patients that could associate with the disease phenotype. In this review, we provide an overview of biomarkers for pediatric BPD and PH that have been identified in clinical studies using various biological fluids. We also present a brief summary of the information available on current strategies and guidelines to prevent and diagnose BPD and PH, as well as their pathophysiology, risk factors, and experimental therapies currently available.
Fil: Rivera, Lidys. State University of Pennsylvania; Estados Unidos
Fil: Siddaiah, Roopa. State University of Pennsylvania; Estados Unidos
Fil: Oji Mmuo, Christiana. State University of Pennsylvania; Estados Unidos
Fil: Silveyra, Gabriela Romina. State University of Pennsylvania; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Biodiversidad y Biología Experimental y Aplicada. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Biodiversidad y Biología Experimental y Aplicada; Argentina
Fil: Silveyra, Patricia. State University of Pennsylvania; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina - Materia
-
Bronchopulmonary Dysplasia
Pulmonary hypertension
Preterm infants
Biomarkers - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/60769
Ver los metadatos del registro completo
id |
CONICETDig_3d8376e53cfdc3c1f84045f2abbee53a |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/60769 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Biomarkers for Bronchopulmonary Dysplasia in the Preterm InfantRivera, LidysSiddaiah, RoopaOji Mmuo, ChristianaSilveyra, Gabriela RominaSilveyra, PatriciaBronchopulmonary DysplasiaPulmonary hypertensionPreterm infantsBiomarkershttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Bronchopulmonary dysplasia (BPD) is a chronic inflammatory lung disease of very-low-birth-weight (VLBW) preterm infants, associated with arrested lung development and a need for supplemental oxygen. Over the past few decades, the incidence of BPD has significantly raised as a result of improved survival of VLBW infants requiring mechanical ventilation. While early disease detection is critical to prevent chronic lung remodeling and complications later in life, BPD is often difficult to diagnose and prevent due to the lack of good biomarkers for identification of infants at risk, and overlapping symptoms with other diseases, such as pulmonary hypertension (PH). Due to the current lack of effective treatment available for BPD and PH, research is currently focused on primary prevention strategies, and identification of biomarkers for early diagnosis, that could also represent potential therapeutic targets. In addition, novel histopathological, biochemical, and molecular factors have been identified in the lung tissue and in biological fluids of BPD and PH patients that could associate with the disease phenotype. In this review, we provide an overview of biomarkers for pediatric BPD and PH that have been identified in clinical studies using various biological fluids. We also present a brief summary of the information available on current strategies and guidelines to prevent and diagnose BPD and PH, as well as their pathophysiology, risk factors, and experimental therapies currently available.Fil: Rivera, Lidys. State University of Pennsylvania; Estados UnidosFil: Siddaiah, Roopa. State University of Pennsylvania; Estados UnidosFil: Oji Mmuo, Christiana. State University of Pennsylvania; Estados UnidosFil: Silveyra, Gabriela Romina. State University of Pennsylvania; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Biodiversidad y Biología Experimental y Aplicada. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Biodiversidad y Biología Experimental y Aplicada; ArgentinaFil: Silveyra, Patricia. State University of Pennsylvania; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFrontiers Media S.A.2016-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/60769Rivera, Lidys; Siddaiah, Roopa; Oji Mmuo, Christiana; Silveyra, Gabriela Romina; Silveyra, Patricia; Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant; Frontiers Media S.A.; Frontiers in Pediatrics; 4; 3-2016; 1-172296-23602296-2360CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/articles/10.3389/fped.2016.00033/fullinfo:eu-repo/semantics/altIdentifier/doi/10.3389/fped.2016.00033info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:08:22Zoai:ri.conicet.gov.ar:11336/60769instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:08:22.458CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant |
title |
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant |
spellingShingle |
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant Rivera, Lidys Bronchopulmonary Dysplasia Pulmonary hypertension Preterm infants Biomarkers |
title_short |
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant |
title_full |
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant |
title_fullStr |
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant |
title_full_unstemmed |
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant |
title_sort |
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant |
dc.creator.none.fl_str_mv |
Rivera, Lidys Siddaiah, Roopa Oji Mmuo, Christiana Silveyra, Gabriela Romina Silveyra, Patricia |
author |
Rivera, Lidys |
author_facet |
Rivera, Lidys Siddaiah, Roopa Oji Mmuo, Christiana Silveyra, Gabriela Romina Silveyra, Patricia |
author_role |
author |
author2 |
Siddaiah, Roopa Oji Mmuo, Christiana Silveyra, Gabriela Romina Silveyra, Patricia |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
Bronchopulmonary Dysplasia Pulmonary hypertension Preterm infants Biomarkers |
topic |
Bronchopulmonary Dysplasia Pulmonary hypertension Preterm infants Biomarkers |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Bronchopulmonary dysplasia (BPD) is a chronic inflammatory lung disease of very-low-birth-weight (VLBW) preterm infants, associated with arrested lung development and a need for supplemental oxygen. Over the past few decades, the incidence of BPD has significantly raised as a result of improved survival of VLBW infants requiring mechanical ventilation. While early disease detection is critical to prevent chronic lung remodeling and complications later in life, BPD is often difficult to diagnose and prevent due to the lack of good biomarkers for identification of infants at risk, and overlapping symptoms with other diseases, such as pulmonary hypertension (PH). Due to the current lack of effective treatment available for BPD and PH, research is currently focused on primary prevention strategies, and identification of biomarkers for early diagnosis, that could also represent potential therapeutic targets. In addition, novel histopathological, biochemical, and molecular factors have been identified in the lung tissue and in biological fluids of BPD and PH patients that could associate with the disease phenotype. In this review, we provide an overview of biomarkers for pediatric BPD and PH that have been identified in clinical studies using various biological fluids. We also present a brief summary of the information available on current strategies and guidelines to prevent and diagnose BPD and PH, as well as their pathophysiology, risk factors, and experimental therapies currently available. Fil: Rivera, Lidys. State University of Pennsylvania; Estados Unidos Fil: Siddaiah, Roopa. State University of Pennsylvania; Estados Unidos Fil: Oji Mmuo, Christiana. State University of Pennsylvania; Estados Unidos Fil: Silveyra, Gabriela Romina. State University of Pennsylvania; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Biodiversidad y Biología Experimental y Aplicada. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Biodiversidad y Biología Experimental y Aplicada; Argentina Fil: Silveyra, Patricia. State University of Pennsylvania; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina |
description |
Bronchopulmonary dysplasia (BPD) is a chronic inflammatory lung disease of very-low-birth-weight (VLBW) preterm infants, associated with arrested lung development and a need for supplemental oxygen. Over the past few decades, the incidence of BPD has significantly raised as a result of improved survival of VLBW infants requiring mechanical ventilation. While early disease detection is critical to prevent chronic lung remodeling and complications later in life, BPD is often difficult to diagnose and prevent due to the lack of good biomarkers for identification of infants at risk, and overlapping symptoms with other diseases, such as pulmonary hypertension (PH). Due to the current lack of effective treatment available for BPD and PH, research is currently focused on primary prevention strategies, and identification of biomarkers for early diagnosis, that could also represent potential therapeutic targets. In addition, novel histopathological, biochemical, and molecular factors have been identified in the lung tissue and in biological fluids of BPD and PH patients that could associate with the disease phenotype. In this review, we provide an overview of biomarkers for pediatric BPD and PH that have been identified in clinical studies using various biological fluids. We also present a brief summary of the information available on current strategies and guidelines to prevent and diagnose BPD and PH, as well as their pathophysiology, risk factors, and experimental therapies currently available. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-03 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/60769 Rivera, Lidys; Siddaiah, Roopa; Oji Mmuo, Christiana; Silveyra, Gabriela Romina; Silveyra, Patricia; Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant; Frontiers Media S.A.; Frontiers in Pediatrics; 4; 3-2016; 1-17 2296-2360 2296-2360 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/60769 |
identifier_str_mv |
Rivera, Lidys; Siddaiah, Roopa; Oji Mmuo, Christiana; Silveyra, Gabriela Romina; Silveyra, Patricia; Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant; Frontiers Media S.A.; Frontiers in Pediatrics; 4; 3-2016; 1-17 2296-2360 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/articles/10.3389/fped.2016.00033/full info:eu-repo/semantics/altIdentifier/doi/10.3389/fped.2016.00033 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Frontiers Media S.A. |
publisher.none.fl_str_mv |
Frontiers Media S.A. |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613951450513408 |
score |
13.070432 |